Skip to main content
. 2021 Jan 4;4:28. doi: 10.1038/s42003-020-01531-x

Fig. 4. BIC2 disrupts oligomeric formation.

Fig. 4

a Modeling of AtCRY2-PHRtetramer complexed with AtBIC2 (red) (superposition of AtCRY2-PHRtetramer with AtCRY2-PHRinactive-BIC2 complex, PDB: 6K8K). Monomers A and B are colored in cyan and pink respectively. H–T interface is shown in green. b Close-up view of BIC2 (red) disrupting H–T interface. Amino acid residues are labeled and colored as indicated in a. c Proposed model of BIC2 inhibition (prepared by BioRender).